1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page confirms the 2026 Grant Round is open but does not display a specific closing date; the stored deadline of 2026-04-02 could not be confirmed from the page.
The Worldwide Cancer Research 2026 Grant Round is a grant from Worldwide Cancer Research that funds discovery-focused cancer research projects across all cancer types and any aspect of cancer biology worldwide. The program prioritizes early-stage, high-risk, high-reward research that challenges existing thinking and opens new avenues for cancer prevention and treatment.
Eligible applicants are researchers at institutions worldwide who meet the organization's funding criteria and research policies. Awards have a maximum budget of £275,000, with typical three-year grants around £200,000. Applications are accepted once per year.
The 2026 grant round deadline was April 2, 2026. Consult the Worldwide Cancer Research website for future grant round information.
Get alerted about grants like this
Get emailed when new opportunities from “Worldwide Cancer Research” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Our Application Process | Worldwide Cancer Research Find out about our application process, how it works and what to expect. Read our grant application handbook, which contains all the information you need to know. We currently accept applications for funding once a year.
Our 2026 Grant Round is open now! Please refer to the page containing information for researchers for more details. Information for researchers Before you begin the process of submitting your application, it is advised that you read all of our funding criteria .
You can only apply for funding if you agree to all of our Terms & Conditions. Stage 1 - Initial eligibility check All applications will be subject to an initial review of eligibility against our funding criteria and research policies . Applications which do not meet these conditions will be rejected at this stage.
Stage 2 - Preliminary triage Remaining applications are sent to our Scientific Advisory Committee for preliminary triage. The committee considers how the application meets the remit of our Research Strategy and how competitive the idea is for funding. We contact all applicants as soon as possible to advise whether they have passed or not passed this preliminary triage.
Please note that we cannot provide feedback. If the lead applicant on an application is rejected at this stage, they cannot resubmit the same research proposal. However, they can submit a new application in the next grant round with a research proposal that is sufficiently different (at least 50%).
Stage 3 - Written expert review Passing applications will be sent out to external peer reviewers for full review. We aim to obtain three external reviews for each application. Additionally, in 2026 we are trialing a Peer Review College to help manage the process of external review and to kick-start a worldwide network of Curestarter reviewers.
We are a member of the Association of Medical Research Charities (AMRC) and as such we follow the AMRC’s high standard and recommended principles of expert review . All applications that include proposals to use mammals with special protection under UK law (cats, horses, dogs and non-human primates) will undergo an additional layer of external review by the UK’s National Centre for the 3Rs for an expert assessment of animal welfare.
For more information please read our use of animals in research policy . Stage 4 - Scientific Advisory Committee meeting After external peer review, the Scientific Advisory Committee will conduct a secondary triage. The remaining applications will be discussed and scored at the Scientific Advisory Committee meeting.
Applications will be awarded funding on the basis of this scoring list until all of the available funds are allocated. Inevitably some high quality projects with good external peer review will not be funded simply because we never have enough money to fund all of high quality ideas that we would love to support.
Stage 5 - Notification of outcome The outcomes of all applications assessed by the Scientific Advisory Committee will be reported to the applicant by email following the meeting. We will also enclose written comments from the external reviewers.
However, please note that we will not enter into any correspondence or discussion regarding the content of reviewer’s comments, or the decision of the Scientific Advisory Committee, which is final.
Read our application handbook Application handbook 2026 Explore our funding criteria Meet our Scientific Advisory Committee Our Scientific Advisory Committee Your application for funding must meet the remit of our Research Strategy and the criteria for funding set out in our application handbook. We have set of research policies that must be adhered to by all grantholders or funding from Worldwide Cancer Research. Find out more here.
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Researchers worldwide conducting discovery research on any cancer type who meet the organization's funding criteria and research policies. Confirm the full requirements in the official notice before applying.
The current listing shows maximum budget of £275,000, typical three-year award around £200,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 2, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Worldwide Cancer Research 2026 Grant Round is funded by Worldwide Cancer Research. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.